References
- Barlyn, S. 2018. Strap on the FitbitL John Hancock to sell only interactive life insurance. Reuters, 20 September 2018. https://www.reuters.com/article/us-manulife-financi-john-hancock-lifeins/strap-on-the-fitbit-john-hancock-to-sell-only-interactive-life-insurance-idUSKCN1LZ1WL.
- Donker, T., K. Petrie, J. Proudfoot, J. Clarke, M. R. Birch, and H. Christensen. 2013. Smartphones for smarter delivery of mental health programs: A systematic review. Journal of Medical Internet Research 15(11): e247.
- Erler, A. 2017. The limits of the treatment-enhancement distinction as a guide to public policy. Bioethics 31(8): 608–615.
- Farrell, A. M., A. Carter, N. Rogasch, and F. Fitzgerald. 2019. Is there a need to regulate consumer use of transcranial direct current stimulation (tDCS) devices? Ethical, safety and legal issues. Medical Journal of Australia 209(1): 8–10.
- Kreitmair, K. 2019. Dimensions of ethical direct-to-consumer neurotechnologies. AJOB Neuroscience 10(4):152–166.
- Lauraitis, A., R. Maskeliunas, R. Damasevicius, D. Polap, and M. Wozniak. 2019. A smartphone application for automated decision support in cognitive task based evaluation of central nervous system motor disorders. IEEE Journal of Biomedical and Health Informatics 23(5): 1865–1876.
- Parker, L., L. Bero, D. Gillies, et al. 2018. Mental health messages in prominent mental health apps. The Annals of Family Medicine 16 (4): 338–342.
- Robillard, J. M., T. L. Feng, A. B. Sporn, et al. 2019. Availability, readability, and content of privacy policies and terms of agreements of mental health apps. Internet Interventions 17: 100243.
- Wexler, A. 2018. Who uses direct-to-consumer brain stimulation products, and why? A study of home users of tDCS devices. Journal of Cognitive Enhancement 2(1): 114–134.
- Yuste, R., S. Goering, B. A. Y. Arcas, et al. 2017. Four ethical priorities for neurotechnologies and AI. Nature 551(7679): 159–163.